Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 12:05 AM
NCT ID:
NCT05805358
Eligibility Criteria:
Inclusion Criteria:
1. Newly diagnosed or recurrent gynecological cancer confirmed by histology.
2. Age ≥ 20 years old.
3. Expected to receive immunotherapy.
Exclusion Criteria:
1. Suffering from other malignancies (excluding non-melanoma skin cancer).
2. History of splenic abnormalities (such as splenic damage, cirrhosis-related splenomegaly or primary/metastatic splenic tumors).
3. Insufficient function of bone marrow, liver and kidney.
4. Contraindications to MRI studies (e.g. claustrophobia, cardiac pacemaker, metal implants in the pelvis).
5. Uncontrolled concurrent diseases, including but not limited to kidney stones, persistent or active infection, symptomatic heart failure, unstable angina, cardiac arrhythmias, or mental illness/social situations that limit compliance with research requirements.
6. Pregnant or lactating women.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
20 Years
Study:
NCT05805358
Study Brief:
Protocol Section:
NCT05805358